DDI-DrugBank.d585.s0 >> The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. >> 69-89,92-101,104-135,144-152,156-169,172-191,200-213,217-231,234-247,250-268,277-286,290-297,303-310,313-334,337-361
DDI-DrugBank.d585.s1 >> Anticholinergics antagonize the effects of antiglaucoma agents. >> 0-15,43-61
DDI-DrugBank.d585.s2 >> Anticholinergic drugs in the presence of increased intraocular pressure may be hazardous when taken concurrently with agents such as corticosteroids. >> 0-20,133-147
DDI-DrugBank.d585.s3 >> Anticholinergic agents may affect gastrointestinal absorption of various drugs, such as slowly dissolving dosage forms of digoxin; >> 0-21,122-128
DDI-DrugBank.d585.s4 >> increased serum digoxin concentrations may result. >> 16-22
DDI-DrugBank.d585.s5 >> Anticholinergic drugs may antagonize the effects of drugs that alter gastrointestinal motility, such as metoclopramide. >> 0-20,104-117
DDI-DrugBank.d585.s6 >> Because antacids may interfere with the absorption of anticholinergic agents, simultaneous use of these drugs should be avoided. >> 8-15,54-75
DDI-DrugBank.d585.s7 >> The inhibiting effects of anticholinergic drugs on gastric hydrochloric acid secretion are antagonized by agents used to treat achlorhydria and those used to test gastric secretion. >> 26-46
